201 related articles for article (PubMed ID: 17555395)
1. Patterns of recurrence and surveillance strategies for renal cell carcinoma following surgical resection.
Breda A; Konijeti R; Lam JS
Expert Rev Anticancer Ther; 2007 Jun; 7(6):847-62. PubMed ID: 17555395
[TBL] [Abstract][Full Text] [Related]
2. Tissue array-based predictions of pathobiology, prognosis, and response to treatment for renal cell carcinoma therapy.
Lam JS; Belldegrun AS; Figlin RA
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6304S-9S. PubMed ID: 15448022
[TBL] [Abstract][Full Text] [Related]
3. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
Lam JS; Shvarts O; Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
J Urol; 2005 Aug; 174(2):466-72; discussion 472; quiz 801. PubMed ID: 16006866
[TBL] [Abstract][Full Text] [Related]
4. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol.
Siddiqui SA; Frank I; Cheville JC; Lohse CM; Leibovich BC; Blute ML
BJU Int; 2009 Sep; 104(6):778-85. PubMed ID: 19338559
[TBL] [Abstract][Full Text] [Related]
5. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
[TBL] [Abstract][Full Text] [Related]
6. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
[TBL] [Abstract][Full Text] [Related]
7. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.
Margulis V; Tamboli P; Matin SF; Swanson DA; Wood CG
Cancer; 2008 Apr; 112(7):1480-8. PubMed ID: 18240184
[TBL] [Abstract][Full Text] [Related]
8. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
[TBL] [Abstract][Full Text] [Related]
9. Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy.
Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
J Urol; 2008 Jul; 180(1):99-103; discussion 103. PubMed ID: 18485415
[TBL] [Abstract][Full Text] [Related]
10. Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma.
Lam JS; Breda A; Belldegrun AS; Figlin RA
J Clin Oncol; 2006 Dec; 24(35):5565-75. PubMed ID: 17158542
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in renal cell carcinoma.
Shuch BM; Lam JS; Belldegrun AS; Figlin RA
Semin Oncol; 2006 Oct; 33(5):563-75. PubMed ID: 17045085
[TBL] [Abstract][Full Text] [Related]
12. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread.
Geller JI; Argani P; Adeniran A; Hampton E; De Marzo A; Hicks J; Collins MH
Cancer; 2008 Apr; 112(7):1607-16. PubMed ID: 18278810
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability.
Eichelberg C; Junker K; Ljungberg B; Moch H
Eur Urol; 2009 Apr; 55(4):851-63. PubMed ID: 19155123
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
[TBL] [Abstract][Full Text] [Related]
15. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus.
Lambert EH; Pierorazio PM; Shabsigh A; Olsson CA; Benson MC; McKiernan JM
Urology; 2007 Jun; 69(6):1054-8. PubMed ID: 17572185
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors and selection for clinical studies of patients with kidney cancer.
Lam JS; Klatte T; Kim HL; Patard JJ; Breda A; Zisman A; Pantuck AJ; Figlin RA
Crit Rev Oncol Hematol; 2008 Mar; 65(3):235-62. PubMed ID: 17931881
[TBL] [Abstract][Full Text] [Related]
17. Current insights in renal cell cancer pathology.
Mancini V; Battaglia M; Ditonno P; Palazzo S; Lastilla G; Montironi R; Bettocchi C; Cavalcanti E; Ranieri E; Selvaggi FP
Urol Oncol; 2008; 26(3):225-38. PubMed ID: 18452811
[TBL] [Abstract][Full Text] [Related]
18. Prognostic models and algorithms in renal cell carcinoma.
Lane BR; Kattan MW
Urol Clin North Am; 2008 Nov; 35(4):613-25; vii. PubMed ID: 18992615
[TBL] [Abstract][Full Text] [Related]
19. Microvascular tumour invasion in renal cell carcinoma: the most important prognostic factor.
Dall'Oglio MF; Antunes AA; Sarkis AS; Crippa A; Leite KR; Lucon AM; Srougi M
BJU Int; 2007 Sep; 100(3):552-5. PubMed ID: 17555475
[TBL] [Abstract][Full Text] [Related]
20. Outcome of nephron-sparing surgery for T1b renal cell carcinoma.
Joniau S; Vander Eeckt K; Srirangam SJ; Van Poppel H
BJU Int; 2009 May; 103(10):1344-8. PubMed ID: 19040528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]